Veterinary Medicines

Klavuxil 140 mg/mL + 35 mg/mL, suspenzija za injekciju, za goveda, pse i mačke

Authorised
  • Amoxicillin trihydrate
  • Clavulanic acid
Download as PDF

Product identification

Medicine name:
Klavuxil 140 mg/mL + 35 mg/mL, suspenzija za injekciju, za goveda, pse i mačke
Active substance:
  • Amoxicillin trihydrate
  • Clavulanic acid
Target species:
  • Cattle
  • Dog
  • Cat
Route of administration:
  • Intramuscular use
  • Subcutaneous use

Product details

Active substance and strength:
  • Amoxicillin trihydrate
    140.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • Clavulanic acid
    35.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Cattle
      • Meat and offal
        42
        day
      • Milk
        60
        hour
  • Subcutaneous use
    • Dog
    • Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01CR02
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Croatia
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Genera d.d.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Genera d.d.
  • Norbrook Laboratories Limited
Responsible authority:
  • Ministry Of Agriculture Veterinary And Food Safety Directorate
Authorisation number:
  • UP/I-322-05/18-01/88
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Croatian (PDF)
Published on: 14/02/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."